Alembic Pharmaceuticals receives USFDA’s approvals for ANDAs

22 Nov 2019 Evaluate

Alembic Pharmaceuticals has received approvals from US Food & Drug Administration (USFDA) for its Abbreviated New Drug Applications (ANDAs). The USFDA has given final approvals for Deferasirox Tablets 90 mg & 360 mg, Deferasirox Tablets for Oral Suspension, 125 mg, 250 mg, & 500 mg, and tentative approval for Deferasirox Tablets 180 mg.

Alembic now has a total of 107 ANDA approvals (95 final approvals and 12 tentative approvals) from USFDA. 

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

899.90 -2.30 (-0.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×